Furans
eMolecules 921194-97-0 | 1H-Indole-3-carboxylicacid,6-chloro-,methylester | MFCD09836004 | 1g
WuXi ChemSupply | 1H-Indole-3-carboxylicacid,6-chloro-,methylester | 1g | 599166822 | LN00337064 | 95.000 | 921194-97-0 | MFCD09836004 | 209.630 | C10H8ClNO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 7168-85-6 | ChemScene | 7-Methoxybenzofuran | 1g | 632283589 | CS-0150289 | MFCD01310825 | 148.161 | C9H8O2
ChemScene | 7-Methoxybenzofuran | 1g | 632283589 | CS-0150289 | 7168-85-6 | MFCD01310825 | 148.161 | C9H8O2
Chemscene ChemScene | 2,5-Furandicarboxylic acid | 100G | CS-W002105 | 0.98 | 3238-40-2| MFCD00016582 | 156.093
ChemScene | 2,5-Furandicarboxylic acid | 100G | CS-W002105 | 0.98 | 3238-40-2| MFCD00016582 | 156.093
Accela Chembio Inc 2 | 5-furandicarboxylic Acid | 25g | 3238-40-2 | MFCD00016582 | 98% | Shelf Life: 1080 Days | Light Sensitive
2 | 5-furandicarboxylic Acid | 25g | 3238-40-2 | MFCD00016582 | 98% | Shelf Life: 1080 Days | Light Sensitive
Medchemexpress LLC MBCQ 50mg | 150450-53-6 | 50 MG
MBCQ is a selective cGMP-specific phosphodiesterase type 5 (PDE5) inhibitor supplied for research use. It exhibits potent PDE5 inhibition (IC50 19 nM) with minimal activity on other PDE isozymes, and is provided as a solid research reagent suitable for biochemical assays and in vivo studies.
- Potent PDE5 inhibition (IC50 19 nM).
- High selectivity versus other PDE isozymes (IC50 >100 μM).
- High purity suitable for research (99.8%).
- Soluble in DMSO at 100 mg/mL for in vitro applications.
- Stable as a powder at -20°C for long-term storage.
- Available in small pack sizes for laboratory use.
Aobchem 2-[(Tetrahydro-3-furanyl)oxy]-4-pyridinecarboxylic acid | 95% | CAS 1211533-45-7 | C10H11NO4 | 500mg
2-[(Tetrahydro-3-furanyl)oxy]-4-pyridinecarboxylic acid | 95% | CAS 1211533-45-7 | C10H11NO4 | 500mg
Aobchem 2-(5-Methyl-2-furanyl)benzaldehyde | ≥95% | CAS 400746-82-9 | C12H10O2 | 500mg
2-(5-Methyl-2-furanyl)benzaldehyde | ≥95% | CAS 400746-82-9 | C12H10O2 | 500mg
![Aobchem 2-[(Tetrahydro-3-furanyl)oxy]-3-pyridinecarboxylic acid | ≥95% | CAS 1343106-79-5 | C10H11NO4 | 250mg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000972843.png-250.jpg)
Aobchem 2-[(Tetrahydro-3-furanyl)oxy]-3-pyridinecarboxylic acid | ≥95% | CAS 1343106-79-5 | C10H11NO4 | 250mg
2-[(Tetrahydro-3-furanyl)oxy]-3-pyridinecarboxylic acid | ≥95% | CAS 1343106-79-5 | C10H11NO4 | 250mg
Medchemexpress LLC Etiocholanolone (5β-Androsterone) | 53-42-9 | 99.5% | 290.44 | 10 MG
Etiocholanolone (5β-Androsterone) is an excreted metabolite of testosterone with anticonvulsant activity. It is also described as a less potent neurosteroid positive allosteric modulator (PAM) of the GABAA receptor compared to its enantiomer form.
- Excreted metabolite of testosterone
- Anticonvulsant activity
- Neurosteroid positive allosteric modulator (PAM) of the GABAA receptor
Medchemexpress LLC ATH686 | 853299-52-2 | 99.5% | 515.53 | 50 MG
ATH686 is a potent, selective, and ATP-competitive FLT3 inhibitor. It targets mutant FLT3 protein kinase activity, inhibiting the proliferation of cells harboring FLT3 mutants by inducing apoptosis and cell cycle inhibition. It has demonstrated antileukemic effects.
- Potent, selective, and ATP-competitive FLT3 inhibitor.
- Targets mutant FLT3 protein kinase activity.
- Induces apoptosis and cell cycle inhibition.
- Inhibits proliferation of cells harboring FLT3 mutants.
- Demonstrates antileukemic effects.
- For research use only.
Medchemexpress LLC Nav1.1 activator 1 | 2332897-85-3 | 99.0% | 440.46 | 10 MG
Nav1.1 activator 1 (compound 4) is a highly potent Nav1.1 activator with BBB penetration, which increases the decay time constant (tau) of Nav1.1 currents at 0.03 μM, demonstrating significant selectivity against Nav1.2, Nav1.5, and Nav1.6.
- A valuable Nav1.1 activator for further evaluation of pathophysiological functions of the Nav1.1 channel.
- Has potential for therapeutic treatments of Central Nervous System (CNS) diseases like Dravet syndrome.
- Intraperitoneal administration (30 mg/kg) in mice achieved sufficient brain exposure (193 ng/g 1 hour after administration), corresponding to 13 nM of free brain concentration, comparable to its in vitro potency.
- Capable of penetrating the blood-brain barrier (BBB) in humans.
Aobchem 2-[(Tetrahydro-3-furanyl)oxy]benzaldehyde | 95% | CAS 925240-81-9 | C11H12O3 | 500mg
2-[(Tetrahydro-3-furanyl)oxy]benzaldehyde | 95% | CAS 925240-81-9 | C11H12O3 | 500mg
Aobchem 2-[(Tetrahydro-3-furanyl)oxy]benzaldehyde | 95% | CAS 925240-81-9 | C11H12O3 | 250mg
2-[(Tetrahydro-3-furanyl)oxy]benzaldehyde | 95% | CAS 925240-81-9 | C11H12O3 | 250mg